Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease
JJ Auletta, KR Cooke - Current opinion in pediatrics, 2009 - journals.lww.com
JJ Auletta, KR Cooke
Current opinion in pediatrics, 2009•journals.lww.comAn exciting era incorporating the use of cellular therapeutics during HSCT has arrived. As
the experience and understanding for cellular therapies, in general, and RSCT, in particular,
increases, so too will their success in benefiting the HSCT recipient beyond limitations of
current pharmaceutical agents.
the experience and understanding for cellular therapies, in general, and RSCT, in particular,
increases, so too will their success in benefiting the HSCT recipient beyond limitations of
current pharmaceutical agents.
Summary
An exciting era incorporating the use of cellular therapeutics during HSCT has arrived. As the experience and understanding for cellular therapies, in general, and RSCT, in particular, increases, so too will their success in benefiting the HSCT recipient beyond limitations of current pharmaceutical agents.
Lippincott Williams & Wilkins